Skip to main content
Top
Published in: BMC Nephrology 1/2023

Open Access 01-12-2023 | Research

Prevalence, associated factors and clinical implications of medication literacy linked to frailty in hemodialysis patients in China: a cross-sectional study

Authors: Linfang Zhu, Yang Liu, Fengxue Yang, Shaobin Yu, Ping Fu, Huaihong Yuan

Published in: BMC Nephrology | Issue 1/2023

Login to get access

Abstract

Background

Maintenance hemodialysis (MHD) patients have complex medication regimens that require a high level of skill to interpret medication information. However, there is currently a lack of research evaluating the ability to read and understand medication labels in Chinese MHD patients. In addition, the relationship between frailty and medication literacy among MHD patients remains unclear. Therefore, this study aims to assess the potential factors affecting medication literacy in MHD patients and to explore the relationship between frailty and medication literacy.

Methods

This cross-sectional study was conducted using convenience sampling in West China Hospital of Sichuan University, China. Using a general questionnaire, we collected demographic, clinical and laboratory data. Medication literacy was assessed by the Chinese Medication Literacy Scale, and frailty was assessed by the FRAIL Scale. Univariate analyses examined potential factors associated with medication literacy. An ordered logistic regression was used to analyze the relationships between medication literacy and these factors. Spearman’s correlation was used to assess the association between medication literacy and frailty.

Results

A total of 290 MHD patients were included in the analysis. Inadequate, marginal, and adequate medication literacy was found in 56 (19.3%), 153 (52.8%), and 81 (27.9%) patients, respectively. Ordered logistic regression revealed factors associated with inadequate medication literacy: age (OR = 0.281, 95% CI = 0.139–0.565, p < 0.001 for < 65 years); education (OR = 8.612, 95% CI = 3.524–21.046, p < 0.001 for ≤ primary school education; OR = 3.405, 95% CI = 1.683–6.887, p = 0.001 for junior high school education); presence of caregiver medication assistance (OR = 2.302, 95% CI = 1.173–4.516, p = 0.015); frailty (OR = 0.440, 95% CI = 0.216–0.893, p = 0.023 for frail patients); and high β2-microglobulin (β2-MG) (OR = 1.010, 95% CI = 1.002–1.019, p = 0.012). Spearman’s analysis showed that medication literacy was negatively correlated with frailty in MHD patients (R=-0.189, p = 0.001).

Conclusions

Medication literacy levels in MHD patients needed improvement and were associated with certain patient characteristics, including age, education level, presence of caregiver support, β2-microglobulin levels, and risk of frailty. This study identified subgroups of MHD patients, such as those who were older, had lower education, had caregiver assistance, had high β2-microglobulin levels, or were frail, to have inadequate medication literacy. These findings underscore the need for routine screening and targeted interventions to improve medication literacy in this population.
Literature
1.
go back to reference Kammerer J, Garry G, Hartigan M, Carter B, Erlich L. Adherence in patients on dialysis: strategies for success. Nephrol Nurs J. 2007;34(5):479–86.PubMed Kammerer J, Garry G, Hartigan M, Carter B, Erlich L. Adherence in patients on dialysis: strategies for success. Nephrol Nurs J. 2007;34(5):479–86.PubMed
9.
go back to reference Wang YP, Yin WC, Yu F, Zhan L, Cao JY, Wei Y, et al. Correlation between medication literacy and self-efficacy in patients with coronary atherosclerotic heart disease after interventional therapy. China Med. 2021;16(12):1774–8. Wang YP, Yin WC, Yu F, Zhan L, Cao JY, Wei Y, et al. Correlation between medication literacy and self-efficacy in patients with coronary atherosclerotic heart disease after interventional therapy. China Med. 2021;16(12):1774–8.
12.
go back to reference Zhang LX, Zhou XJ, Ma LK, Zhan L. Medication literacy status and influencing factors of patients with atrial fibrillation after radiofrequency ablation. Anhui Med Pharm J. 2019;23(12):2527–30. Zhang LX, Zhou XJ, Ma LK, Zhan L. Medication literacy status and influencing factors of patients with atrial fibrillation after radiofrequency ablation. Anhui Med Pharm J. 2019;23(12):2527–30.
13.
go back to reference Xiong Y, Wang GH, Wang XW, Xi KC, Si JF, Zhu CY. Current status and influencing factors of drug literacy in maintenance hemodialysis patients. Military Med J Southeast China. 2022;24(1):86–8. Xiong Y, Wang GH, Wang XW, Xi KC, Si JF, Zhu CY. Current status and influencing factors of drug literacy in maintenance hemodialysis patients. Military Med J Southeast China. 2022;24(1):86–8.
16.
go back to reference Chinese Medical Doctor Association, Expert Collaborative Group on Nutritional Treatment Guidelines of the Renal Disease Committee of Chinese association of integrative medicine. Chinese clinical practice guidelines for Nutritional treatment of chronic kidney disease (2021 edition). Natl Med J China. 2021;101(8):539–59. Chinese Medical Doctor Association, Expert Collaborative Group on Nutritional Treatment Guidelines of the Renal Disease Committee of Chinese association of integrative medicine. Chinese clinical practice guidelines for Nutritional treatment of chronic kidney disease (2021 edition). Natl Med J China. 2021;101(8):539–59.
18.
go back to reference Zheng F, Zhong Z, Ding S, Luo A, Liu Z. Modification and evaluation of assessment of medication literacy. J Cent South Univ(Medical Science). 2016;41(11):1226–31. Zheng F, Zhong Z, Ding S, Luo A, Liu Z. Modification and evaluation of assessment of medication literacy. J Cent South Univ(Medical Science). 2016;41(11):1226–31.
22.
go back to reference Wang L, Li J, Kang W, Cui L. Rational use of drugs in patients with chronic renal impairment in our hospital and typical case analysis. Cent South Pharm. 2019;17(1):121–5. Wang L, Li J, Kang W, Cui L. Rational use of drugs in patients with chronic renal impairment in our hospital and typical case analysis. Cent South Pharm. 2019;17(1):121–5.
26.
go back to reference Cui Y, Lou pengyu, Xu X, Zhou lvlin. Studying on the status of medication literacy of the Elderly and its influencing factors sampled with Shangdong Province. Chin Health Service Manage. 2021;38(6):477–80. Cui Y, Lou pengyu, Xu X, Zhou lvlin. Studying on the status of medication literacy of the Elderly and its influencing factors sampled with Shangdong Province. Chin Health Service Manage. 2021;38(6):477–80.
31.
go back to reference Cao M, Li Q, Feng L, Ma X, Kang L, Yang Q. Chain mediating effect between health literacy and frailty in maintenance hemodialysis patients. Chin J Gen Pract. 2023;21(3):429–33. Cao M, Li Q, Feng L, Ma X, Kang L, Yang Q. Chain mediating effect between health literacy and frailty in maintenance hemodialysis patients. Chin J Gen Pract. 2023;21(3):429–33.
Metadata
Title
Prevalence, associated factors and clinical implications of medication literacy linked to frailty in hemodialysis patients in China: a cross-sectional study
Authors
Linfang Zhu
Yang Liu
Fengxue Yang
Shaobin Yu
Ping Fu
Huaihong Yuan
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2023
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03346-4

Other articles of this Issue 1/2023

BMC Nephrology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine